As of 2024-12-15, the Fair Value of Finch Therapeutics Group Inc (FNCH) is -7.04 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.80 USD, the upside of Finch Therapeutics Group Inc is -490.84%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -39.34 | -58.16 | -114.65 | -74.75 | -71.73 | |
| YoY growth | -89.59% | -47.84% | -97.13% | 34.80% | -49.94% | |
| Market Cap (mil) | 18.13 |
| P/E | |
| Forward P/E |
| EPS | -1.41 |
| Avg earnings growth rate | -49.94% |
| TTM earnings | -14.17 |